Treatment of Cushing's disease: a mechanistic update

Ketoconazole in Cushing's Disease: Is It Worth a Try?

(2014) Frederic Castinetti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Somatostatin receptor ligands and resistance to treatment in pituitary adenomas

(2014) Daniel Cuevas-Ramos et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists

(2013) R. van der Pas et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Medical Treatment of Cushing's Disease

(2013) Richard A. Feelders et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Outcome of Bilateral Adrenalectomy in Cushing's Syndrome: A Systematic Review

(2013) Katrin Ritzel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study

(2013) Xavier Bertagna et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy

(2013) Maria Fleseriu et al.   JOURNAL OF NEURO-ONCOLOGY

Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?

(2013) M. Barbot et al.   Pituitary

Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations

(2013) Annamaria Colao et al.   Pituitary

Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease

(2013) L. Du et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center

(2012) Camille Baudry et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

THERAPY IN ENDOCRINE DISEASE: Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review

(2012) Veronica A Preda et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling

(2012) L. Budry et al.   GENES & DEVELOPMENT

Potential Role for Retinoic Acid in Patients with Cushing's Disease

(2012) Francesca Pecori Giraldi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome

(2012) Maria Fleseriu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Fluconazole inhibits human adrenocortical steroidogenesis in vitro

(2012) R van der Pas et al.   JOURNAL OF ENDOCRINOLOGY

Medical Management of Persistent and Recurrent Cushing Disease

(2012) Maria Fleseriu   NEUROSURGERY CLINICS OF NORTH AMERICA

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

(2012) Annamaria Colao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Medical management of Cushing’s disease: what is the future?

(2012) Maria Fleseriu et al.   Pituitary

Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension

(2011) David A. Calhoun et al.   CIRCULATION

Mortality and morbidity in Cushing’s syndrome in New Zealand

(2011) Mark J. Bolland et al.   CLINICAL ENDOCRINOLOGY

Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma

(2011) Matthias Kroiss et al.   CLINICAL ENDOCRINOLOGY

Changes in heart valve structure and function in patients treated with dopamine agonists for prolactinomas, a 2-year follow-up study

(2011) Victoria Delgado et al.   CLINICAL ENDOCRINOLOGY

The Calcium-Sensing Receptor: A Molecular Perspective

(2011) Aaron L. Magno et al.   ENDOCRINE REVIEWS

The role of somatostatin and dopamine D2 receptors in endocrine tumors

(2011) Federico Gatto et al.   ENDOCRINE-RELATED CANCER

DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours

(2011) U Plöckinger et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing's Syndrome

(2011) Peter Kamenický et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mifepristone Effects on Tumor Somatostatin Receptor Expression in Two Patients with Cushing's Syndrome due to Ectopic Adrenocorticotropin Secretion

(2011) C. de Bruin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas

(2011) Hidenori Fukuoka et al.   JOURNAL OF CLINICAL INVESTIGATION

Management of Cushing disease

(2011) Nicholas A. Tritos et al.   Nature Reviews Endocrinology

Medical suppression of hypercortisolemia in Cushing’s syndrome with particular consideration of etomidate

(2011) Jens Heyn et al.   Pituitary

Anti-VEGF therapy in pituitary carcinoma

(2011) Leon D. Ortiz et al.   Pituitary

Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor

(2011) N.-A. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Rosiglitazone Revisited

(2010) Steven E. Nissen et al.   ARCHIVES OF INTERNAL MEDICINE

Treatment of pituitary neoplasms with temozolomide

(2010) Luis V. Syro et al.   CANCER

The incidence and prevalence of Cushing’s disease may be higher than previously thought: results from a retrospective study in Iceland 1955 through 2009

(2010) Steinunn Arnardóttir et al.   CLINICAL ENDOCRINOLOGY

Efficacy of Cabergoline in Uncured (Persistent or Recurrent) Cushing Disease After Pituitary Surgical Treatment with or without Radiotherapy

(2010) Anurag Lila et al.   Endocrine Practice

Ion Channels and Signaling in the Pituitary Gland

(2010) Stanko S. Stojilkovic et al.   ENDOCRINE REVIEWS

Cabergoline monotherapy in the long-term treatment of Cushing's disease

(2010) Ariane Godbout et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases

(2010) H. Bode et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Possible Relevance between Prohormone Convertase 2 Expression and Tumor Growth in Human Adrenocorticotropin-Producing Pituitary Adenoma

(2010) Kazumi Iino et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Role of the PPAR-γ System in Normal and Tumoral Pituitary Corticotropic Cells and Adrenal Cells

(2010) Massimo Mannelli et al.   NEUROENDOCRINOLOGY

Management of Dyslipidemia in Cushing’s Syndrome

(2010) Yona Greenman   NEUROENDOCRINOLOGY

Medical Treatment of Cushing’s Syndrome: Adrenal-Blocking Drugs and Ketaconazole

(2010) Richard A. Feelders et al.   NEUROENDOCRINOLOGY

Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease

(2010) Richard A. Feelders et al.   NEW ENGLAND JOURNAL OF MEDICINE

Temozolomide for corticotroph pituitary adenomas refractory to standard therapy

(2010) Troy H. Dillard et al.   Pituitary

Role of Receptor-Interacting Protein 140 in human fat cells

(2010) Niklas Mejhert et al.   BMC Endocrine Disorders

Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study

(2009) Krystallenia I. Alexandraki et al.   CLINICAL ENDOCRINOLOGY

Merits and pitfalls of mifepristone in Cushing's syndrome

(2009) F Castinetti et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Pregnancy and pituitary disorders

(2009) Z Karaca et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas

(2009) Zhi Rong Qian et al.   MODERN PATHOLOGY

Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing’s disease

(2009) Lucio Vilar et al.   Pituitary

Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease

(2008) F Castinetti et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement

(2008) B. M. K. Biller et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors

(2008) Fernando Colbari Amaral et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial

(2008) M. Boscaro et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery

(2008) Rosario Pivonello et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Somatostatin and dopamine receptors as targets for medical treatment of Cushing’s Syndrome

(2008) C. de Bruin et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas

(2008) Marta Labeur et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Management of recurrent and refractory Cushing disease

(2008) Manish K Aghi   Nature clinical practice. Endocrinology & metabolism

Bilateral laparoscopic adrenalectomy for corticotrophin–dependent Cushing's syndrome: a review of the Mayo Clinic experience

(2007) John T. Chow et al.   CLINICAL ENDOCRINOLOGY

Late Recurrences of Cushing’s Disease after Initial Successful Transsphenoidal Surgery

(2007) Chirag G. Patil et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM